{"id":23553,"date":"2025-11-06T11:01:07","date_gmt":"2025-11-06T11:01:07","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=23553"},"modified":"2025-11-06T11:01:07","modified_gmt":"2025-11-06T11:01:07","slug":"next-oncology-partners-with-kansai-medical-university","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/next-oncology-partners-with-kansai-medical-university\/","title":{"rendered":"NEXT\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u3001\u95a2\u897f\u533b\u79d1\u5927\u5b66\u3068\u63d0\u643a"},"content":{"rendered":"<?xml encoding=\"utf-8\" ?><p>Presence of NEXT Oncology, in the Avacare portfolio, is expanded to Asia through joint venture with Kansai Medical University in Osaka, Japan. The move strengthens its position as one of the world&rsquo;s largest Phase I cancer trial organizations.<\/p><p>\u7b2c I \u76f8\u81e8\u5e8a\u8a66\u9a13\u30d7\u30ed\u30b0\u30e9\u30e0\u306e\u8cac\u4efb\u8005\u3067\u3042\u308b\u6e05\u6c34\u4fca\u592b\u535a\u58eb\u306e\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u306e\u4e0b\u3001\u3053\u306e\u63d0\u643a\u306b\u3088\u308a\u3001\u65e5\u672c\u306e\u60a3 \u8005\u3055\u3093\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a NEXT Oncology \u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u306e\u4e2d\u3067\u65e9\u671f\u81e8\u5e8a\u8a66\u9a13\u306b\u30a2\u30af\u30bb\u30b9\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002\u95a2\u897f\u533b\u79d1\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u65b0\u5b9f\u9a13\u6cbb\u7642\u5b66\u8b1b\u5ea7\u6559\u6388\u30fb\u65e9\u671f\u7b2c\u2160\u76f8\u8a66\u9a13\u90e8\u9577\u3067\u3042\u308b\u6e05\u6c34\u306f\u3001\u304c\u3093\u7814\u7a76\u306b\u304a\u3051\u308b\u9577\u5e74\u306e\u7d4c\u9a13\u3092\u6709\u3057\u3066\u3044\u307e\u3059\u3002.<\/p><p>Guided early in his career by NEXT Oncology&rsquo;s CEO and Founder, Dr. Anthony W. Tolcher, Dr. Shimizu completed an advanced clinical fellowship in early Phase I drug development in San Antonio between 2010 and 2012. He later led numerous oncology trials at the National Cancer Center Hospital in Tokyo from 2016 to 2022. In November 2024, he launched a global first-in-human oncology trial platform at <a href=\"https:\/\/www.kmu.ac.jp\/\" data-no-translation=\"\">Kansai Medical University<\/a> \u75c5\u9662\u3067\u306f\u3001\u73fe\u572820\u4ee5\u4e0a\u306e\u6d3b\u767a\u306a\u7b2cI\u76f8\u8a66\u9a13\u304c\u9032\u884c\u4e2d\u3067\u3059\u3002.<\/p><h4>\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a class=\"p-url\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/offline-studio-partners-with-corundum-for-life-sciences-projects\/\" rel=\"bookmark\">\u30aa\u30d5\u30e9\u30a4\u30f3\u30fb\u30b9\u30bf\u30b8\u30aa\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u30fb\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u3067\u30b3\u30e9\u30f3\u30c0\u30e0\u3068\u63d0\u643a<\/a><\/h4><p><a href=\"https:\/\/nextoncology.com\/\" data-no-translation=\"\">NEXT Oncology<\/a> currently operates centers in San Antonio, Austin, Dallas, and Houston in Texas, as well as Arlington, Virginia; Barcelona and Madrid, Spain; S&atilde;o Paulo, Brazil; and now Osaka, Japan. The organization treats more than 1,000 patients annually and continues to grow its global reach in early cancer drug development.<\/p>","protected":false},"excerpt":{"rendered":"<p>Presence of NEXT Oncology, in the Avacare portfolio, is expanded to Asia through joint venture with Kansai Medical University in Osaka, Japan. The move strengthens its position as one of the world&rsquo;s largest Phase I cancer trial organizations.Under the leadership of Dr. Toshio Shimizu, who will head the Phase I program, the partnership will give patients in Japan access to early-stage clinical trials within the global NEXT Oncology network. Dr. Shimizu, a Professor in the Department of New Experimental Therapeutics and Director of Early Phase I Drug Development Services at Kansai Medical University Hospital, brings years of experience in oncology research.Guided early in his career by NEXT Oncology&rsquo;s CEO and [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":23554,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,181,89,211,237,206],"tags":[150,9030,9031,9032,9029],"ppma_author":[572],"class_list":["post-23553","post","type-post","status-publish","format-standard","has-post-thumbnail","category-apac","category-biotech","category-health-tech","category-japan","category-news","category-regional","tag-biotech","tag-cancer-therapy","tag-kansai-medical-university","tag-next-oncology","tag-phase-i-cancer-trial"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NEXT Oncology and Kansai Medical Join Forces in Japan<\/title>\n<meta name=\"description\" content=\"NEXT Oncology has entered Japan through a joint venture with Kansai Medical University, expanding its global cancer trial network.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/next-oncology-partners-with-kansai-medical-university\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NEXT Oncology and Kansai Medical Join Forces in Japan\" \/>\n<meta property=\"og:description\" content=\"NEXT Oncology has entered Japan through a joint venture with Kansai Medical University, expanding its global cancer trial network.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/next-oncology-partners-with-kansai-medical-university\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-06T11:01:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/11\/NEXT-Oncology-Expands-to-Japan-in-Joint-Venture-Partnership-With-Kansai-Medical-University.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NEXT\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u3068\u95a2\u897f\u30e1\u30c7\u30a3\u30ab\u30eb\u304c\u65e5\u672c\u3067\u63d0\u643a","description":"NEXT\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u306f\u3001\u95a2\u897f\u533b\u79d1\u5927\u5b66\u3068\u306e\u30b8\u30e7\u30a4\u30f3\u30c8\u30d9\u30f3\u30c1\u30e3\u30fc\u3092\u901a\u3058\u3066\u65e5\u672c\u306b\u9032\u51fa\u3057\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u304c\u3093\u81e8\u5e8a\u8a66\u9a13\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u3092\u62e1\u5927\u3057\u3066\u3044\u307e\u3059\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/next-oncology-partners-with-kansai-medical-university\/","og_locale":"ja_JP","og_type":"article","og_title":"NEXT Oncology and Kansai Medical Join Forces in Japan","og_description":"NEXT Oncology has entered Japan through a joint venture with Kansai Medical University, expanding its global cancer trial network.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/next-oncology-partners-with-kansai-medical-university\/","og_site_name":"itbusinesstoday","article_published_time":"2025-11-06T11:01:07+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/11\/NEXT-Oncology-Expands-to-Japan-in-Joint-Venture-Partnership-With-Kansai-Medical-University.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/next-oncology-partners-with-kansai-medical-university\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/next-oncology-partners-with-kansai-medical-university\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"NEXT Oncology Partners with Kansai Medical University","datePublished":"2025-11-06T11:01:07+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/next-oncology-partners-with-kansai-medical-university\/"},"wordCount":246,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/next-oncology-partners-with-kansai-medical-university\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/11\/NEXT-Oncology-Expands-to-Japan-in-Joint-Venture-Partnership-With-Kansai-Medical-University.webp","keywords":["Biotech","cancer therapy","Kansai Medical University","NEXT Oncology","Phase I Cancer Trial"],"articleSection":["APAC","Biotech","Health Tech","Japan","News","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/next-oncology-partners-with-kansai-medical-university\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/next-oncology-partners-with-kansai-medical-university\/","name":"NEXT\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u3068\u95a2\u897f\u30e1\u30c7\u30a3\u30ab\u30eb\u304c\u65e5\u672c\u3067\u63d0\u643a","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/next-oncology-partners-with-kansai-medical-university\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/next-oncology-partners-with-kansai-medical-university\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/11\/NEXT-Oncology-Expands-to-Japan-in-Joint-Venture-Partnership-With-Kansai-Medical-University.webp","datePublished":"2025-11-06T11:01:07+00:00","description":"NEXT\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u306f\u3001\u95a2\u897f\u533b\u79d1\u5927\u5b66\u3068\u306e\u30b8\u30e7\u30a4\u30f3\u30c8\u30d9\u30f3\u30c1\u30e3\u30fc\u3092\u901a\u3058\u3066\u65e5\u672c\u306b\u9032\u51fa\u3057\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u304c\u3093\u81e8\u5e8a\u8a66\u9a13\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u3092\u62e1\u5927\u3057\u3066\u3044\u307e\u3059\u3002.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/next-oncology-partners-with-kansai-medical-university\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/biotech\/next-oncology-partners-with-kansai-medical-university\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/next-oncology-partners-with-kansai-medical-university\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/11\/NEXT-Oncology-Expands-to-Japan-in-Joint-Venture-Partnership-With-Kansai-Medical-University.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/11\/NEXT-Oncology-Expands-to-Japan-in-Joint-Venture-Partnership-With-Kansai-Medical-University.webp","width":1200,"height":800,"caption":"NEXT Oncology"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/next-oncology-partners-with-kansai-medical-university\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"NEXT Oncology Partners with Kansai Medical University"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"author_category":"","first_name":"ITBT","last_name":"StaffWriter","user_url":"https:\/\/itbusinesstoday.com\/","job_title":"","description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002"}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/23553","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=23553"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/23553\/revisions"}],"predecessor-version":[{"id":23555,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/23553\/revisions\/23555"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/23554"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=23553"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=23553"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=23553"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=23553"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}